Checked 2026-11-10. Independent clinical review has not been completed. WADAFUK is independent of WADA and does not provide medical advice or an individual anti-doping determination.
Prohibited at all times
2026 S4.4.1: prohibited at all times. Non-Specified. [1]
S4.4.1 · 2026 rules apply from 1 January 2026. Any 2027 material below concerns future rules from 1 January 2027; it is not current clearance.
Preclinical evidence
BAM15 is a mitochondria-targeted protonophore studied for uncoupling cellular energy metabolism. In cell experiments and diet-induced-obesity mouse models, investigators observed metabolic effects including sustained AMPK activation and reduced weight gain. These are preclinical findings, not demonstrated human weight-loss or exercise benefits. [2]
- No administered-human efficacy or adequate human safety evidence was established by this source.
Exposure evidence
WADA’s 2026 explanatory notes state that BAM15 has been found in supplements. That notice does not provide an independently assessable brand-by-brand or batch-by-batch dataset. [3]
- An official exposure statement is not a measure of market prevalence.
Check the sources.
These are concise editorial paraphrases of selected sources, not a systematic review or a reproduction of source tables. Access depth is shown for each reference; an abstract-only check cannot resolve details found only in a full paper.
- WADA 2026 Prohibited List ↗Accessed 2026-11-10 · Relevant official full-text sections opened
Printed pp. 3, 9–12: introduction, S3, S4 and S5 as applicable
- BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control ↗Accessed 2026-11-10 · Relevant document text opened
Relevant cited sections
- WADA 2026 explanatory notes ↗Accessed 2026-11-10 · Relevant document text opened
p. 1, S3 and S4 explanatory notes
Check the current official WADA List and the relevant anti-doping authority for your sport, product, route and circumstances. Do not stop or change necessary treatment based on this page. Ask a qualified clinician about health decisions. Missing evidence does not establish safety.